pH-Sensitive doxorubicin delivery using zinc oxide nanoparticles as a rectified theranostic platform: in vitro anti-proliferative, apoptotic, cell cycle arrest and in vivo radio-distribution studies

Abstract

An innovative pH-responsive and biocompatible agent (Tc-99m labelled DOX-loaded ZnO@dextran) is developed as an intelligent platform for tumor-targeted theranostic applications.